Medtronic
FDA, CMS Make Parallel Review Program Permanent; Will Device and Diagnostic Companies Engage?
Premium
After a five-year pilot, only one company has successfully taken a test through parallel review, but there is growing industry interest.
Title: Methods for Diagnosing Prostate Cancer using microRNAs
Patent Number: 8,557,520
Filed: Feb. 28, 2012
Lead Inventor: Carlo Croce, Ohio State University
Researchers Detail Use of Precision Medicine in Mental Illness Case
NEW YORK (GenomeWeb News) – In a sort of test case for personalized medicine, a team of clinicians and researchers used whole-genome sequencing to uncover variants possibly linked to a patient's obsessive-compulsive disorder.
Response Genetics, Taiho Extend MDx Services Pact
Response Genetics could receive up to $950,000 for molecular diagnostic testing services provided to Taiho Pharmaceutical related to the development of cancer treatments.
Dutch gene therapy firm UniQure and academic collaborators have been awarded a three-year grant worth €2.5 million ($3.2 million) from the European Commission to develop a treatment for Huntington’s disease that combines RNAi and gene replacement.
May 10, 2012
Nov 4, 2010
Jul 22, 2010
Sep 17, 2009
Aug 20, 2009
Mar 12, 2009